Elpipodect (MK-8189) Multiple Dose Study in Healthy Volunteers and Schizophrenia Participants (MK-8189-003)
Clinical trial NCT02181803 · COMPLETED
Trial details
- NCT number
- NCT02181803
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-05
- Primary completion
- 2015-04-23
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.